secwatch.observer — SEC 8-K summary
======================================

Issuer:     Calidi Biotherapeutics, Inc. (CLDI)
CIK:        0001855485
Form:       8-K
Filed at:   2024-08-22T23:59:59+00:00
Accession:  0001493152-24-033579
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Calidi Biotherapeutics posts presentation on new wholly owned subsidiary Redtail Biopharma
--------------------------------------------------------------------------------

- Presentation made available August 22, 2024 on company website.
- Redtail Biopharma, Inc. is a new wholly owned subsidiary of Calidi Biotherapeutics.
- No financial terms or strategic details disclosed in the 8-K or presentation excerpt.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855485/000149315224033579/0001493152-24-033579-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855485/000149315224033579/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-033579

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer